HUP0600814A3 - Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds - Google Patents

Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds

Info

Publication number
HUP0600814A3
HUP0600814A3 HU0600814A HUP0600814A HUP0600814A3 HU P0600814 A3 HUP0600814 A3 HU P0600814A3 HU 0600814 A HU0600814 A HU 0600814A HU P0600814 A HUP0600814 A HU P0600814A HU P0600814 A3 HUP0600814 A3 HU P0600814A3
Authority
HU
Hungary
Prior art keywords
compounds
angiogenesis
peptides
activation
containing same
Prior art date
Application number
HU0600814A
Other languages
English (en)
Original Assignee
Biostatin Gyogyszerkutato Fejl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biostatin Gyogyszerkutato Fejl filed Critical Biostatin Gyogyszerkutato Fejl
Priority to HU0600814A priority Critical patent/HUP0600814A3/hu
Publication of HU0600814D0 publication Critical patent/HU0600814D0/hu
Priority to PCT/HU2007/000095 priority patent/WO2008050161A2/en
Publication of HUP0600814A2 publication Critical patent/HUP0600814A2/hu
Publication of HUP0600814A3 publication Critical patent/HUP0600814A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HU0600814A 2006-10-27 2006-10-27 Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds HUP0600814A3 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU0600814A HUP0600814A3 (en) 2006-10-27 2006-10-27 Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds
PCT/HU2007/000095 WO2008050161A2 (en) 2006-10-27 2007-10-19 Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0600814A HUP0600814A3 (en) 2006-10-27 2006-10-27 Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds

Publications (3)

Publication Number Publication Date
HU0600814D0 HU0600814D0 (en) 2006-12-28
HUP0600814A2 HUP0600814A2 (en) 2008-07-28
HUP0600814A3 true HUP0600814A3 (en) 2009-08-28

Family

ID=89987111

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0600814A HUP0600814A3 (en) 2006-10-27 2006-10-27 Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds

Country Status (2)

Country Link
HU (1) HUP0600814A3 (hu)
WO (1) WO2008050161A2 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201018125D0 (en) * 2010-10-26 2010-12-08 Marealis As Peptide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06172383A (ja) * 1992-04-07 1994-06-21 Ichikawa Gosei Kagaku Kk ペプチド置換ポルフィリンの製造方法
WO2003020215A2 (en) * 2001-08-29 2003-03-13 Regenerx Biopharmaceuticals, Inc. Methods of treating mycocardial event related coditions with thymosin beta 4
US6987167B2 (en) * 2002-05-22 2006-01-17 Wockhardt Limited Process for production of the somatostatin analog, octreotide

Also Published As

Publication number Publication date
WO2008050161A3 (en) 2008-10-02
HUP0600814A2 (en) 2008-07-28
HU0600814D0 (en) 2006-12-28
WO2008050161A2 (en) 2008-05-02

Similar Documents

Publication Publication Date Title
IL225198A (en) Aminotetrahydropyrenic Compounds, Pharmaceutical Preparations Containing Them and Their Use in the Treatment of Diabetes
IL199397A (en) Hetero-ring compounds, pharmaceuticals containing them, and their medicinal products
ZA200808530B (en) Pharmaceutical composition for external use
ZA200808531B (en) Pharmaceutical composition for external use
IL187635A0 (en) Amylases for pharmaceutical use
ZA200801275B (en) Pharmaceutical preparation containing meloxicam
IL198289A (en) Processed dihydropyrazolones, processes for their preparation, medicinal preparations containing them and their use in the preparation of medicinal preparations
GB0608820D0 (en) Pharmaceutical compounds
ZA200810164B (en) Sustained release pharmaceutical dosage form containing phenylphrine
EP2143724A4 (en) NUCLEOUS FUSED CYBLE DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF FOR MEDICAL USES
IL212789A0 (en) Cartridge, pharmaceutical dispenser for solid pharmacetical portions and applications of said cartridge and said pharmaceutical dispenser
HK1134902A1 (en) Compounds a-r-x for the manufacture of pharmaceutical preparations
ZA200907450B (en) Stabilised pharmaceutical composition containing pregabaline
ZA200900673B (en) 18-methyl-19-nor-androst-4-en-17, 17-spiroether (18-methyl-19-nor-20-spirox-4-en-3-one) and pharmaceutical preparations containing the same
IL238404A (en) A drug composition containing an isolated peptide for the treatment of influenza infection
ZA200807348B (en) Dosage aerosols for the administration of pharmaceutical preparations
IL192824A (en) Peptide compounds, pharmaceuticals containing them and their use
IL198634A0 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
GB0608184D0 (en) Pharmaceutical compounds
GB0608176D0 (en) Pharmaceutical Compounds
HUP0600814A3 (en) Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds
ZA200808769B (en) Pharmaceutical compostion containing the NMB0938 protein
HU0700782D0 (en) Novel peptides and amino acid derivatives, pharmaceutical compositions containing the same and use of these compounds
GB0608264D0 (en) Pharmaceutical compounds
GB0608175D0 (en) Pharmaceutical Compounds

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished